Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://alyssawymn401079.ziblogs.com/39323226/emerging-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment